ARROWDEAN LTD has a total of 14 patent applications. Its first patent ever was published in 1992. It filed its patents most often in Canada, EPO (European Patent Office) and United States. Its main competitors in its focus markets pharmaceuticals, machines and medical technology are DOLORGIET GMBH & CO KG, SANOFI SYNTHELABO INC and ANALGESIC ASSOCIATES.
# | Country | Total Patents | |
---|---|---|---|
#1 | Canada | 4 | |
#2 | EPO (European Patent Office) | 4 | |
#3 | United States | 3 | |
#4 | Germany | 2 | |
#5 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Machines | |
#3 | Medical technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Unspecified technologies | |
#4 | Diagnosis and surgery |
# | Name | Total Patents |
---|---|---|
#1 | Mattern Claudia | 13 |
#2 | Haecker Ruediger | 6 |
#3 | Haecker Ruediger Prof Dr | 3 |
#4 | Hacker Ruediger | 2 |
#5 | Hacker Rudiger | 2 |
#6 | Sedlak Libor Dr | 1 |
#7 | Svoboda Tomas Dr | 1 |
#8 | Haekker Ruediger | 1 |
#9 | Mattern Claudia Dr | 1 |
Publication | Filing date | Title |
---|---|---|
US5756071A | Method for nasally administering aerosols of therapeutic agents to enhance penetration of the blood brain barrier | |
EP0812569A1 | Method of determining the bioavailability and/or blood-brain barrier permeability of a chemical compound | |
DE4317868A1 | Novel anxiolytic | |
CA2113425A1 | Androgens for stimulating the central nervous system and for treating osteoporosis | |
CA2135203A1 | Metering spray designed for pernasal application | |
DE4214953A1 | Medicines to increase testosterone levels |